HER-2/neu splicing variant expression in human breast cancer: Comparison of RT-PCR and immunohistochemistry and fluorescence in situ hybridization

被引：0
|
作者：
Nazaka, H.
Kazama, R.
Kouga, H.
Muramatsu, A.
Arai, C.
Zheng, Z.
Miura, T.
Kasai, K.
Sato, T.
Okusawa, E.
Katayama, Y.
Uesugi, N.
Sugai, T.
Nakamura, S.
机构：
[1] Hirosaki Univ, Hirosaki, Aomori, Japan
[2] Hokkaido PWFAC Obihiro, Kosei Gen Hosp, Obihiro, Hokkaido, Japan
[3] City Hosp, Hachinohe, Aomori, Japan
[4] Iwate Med Univ, Morioka, Iwate 020, Japan
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
206
引用
收藏
页码：47A / 47A
页数：1
相关论文
共 50 条
  • [31] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization
    Aswin Shanmugalingam
    Kerry Hitos
    Nirmala Pathmanathan
    Senarath Edirimmane
    T. Michael Hughes
    Nicholas K. Ngui
    Breast Cancer Research and Treatment, 2023, 198 : 143 - 148
  • [32] HER-2/neu overexpression:: immunohistochemistry (IHC) or fluorescence in-situ hybridization (FISH)?
    Bunis, JA
    Weaver, DL
    Wells, WA
    Cole, BF
    Memoli, V
    Cates, J
    Schwartz, G
    Muss, HB
    Kaufman, PA
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S142 - S142
  • [33] Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer
    Rosenthal, SI
    Depowski, PL
    Sheehan, CE
    Ross, JS
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (01): : 40 - 46
  • [34] Correlation of HER-2/neu immunohistochemistry with fluorescence in situ hybridization in 3,568 breast cancers.
    Da Silva, MM
    Horten, BC
    Owens, MA
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S68 - S68
  • [35] Comparison of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for the evaluation of HER2/neu in breast cancer.
    Jacobs, TW
    Barnes, MJ
    Yaziji, H
    Gown, AM
    Schnitt, SJ
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [36] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in-situ-hybridization
    Shanmugalingam, A.
    Hitos, K.
    Pathmanathan, N.
    Edirimmane, S.
    Hughes, M. T.
    Ngui, N. K.
    BREAST, 2023, 68 : S29 - S29
  • [37] Suggestions for HER-2/neu testing in breast carcinoma, based on a comparison of immunohistochemistry and fluorescence in situ hybridisation
    Field, AS
    Chamberlain, NL
    Tran, D
    Morey, AL
    PATHOLOGY, 2001, 33 (03) : 278 - 282
  • [38] Evaluation of Genetic Status of HER-2/neu and Aneusomy 17 by Fluorescence In Situ Hybridization and Comparison with Immunohistochemistry Assay from Indian Breast Cancer Patients
    Kokate, Prajakta
    Sawaimoon, Satyakam
    Bhatia, Simi
    Mandava, Swarna
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (04) : 239 - 245
  • [39] Correlation of quantitative Her-2/neu gene expression (TaqMan PCR) with standard immunohistochemistry and fluorescence in situ hybridization in core needle biopsies.
    Lenhard, M. S.
    Wirtz, R. M.
    Rueckert, S.
    Hasmueller, S.
    Ditsch, N.
    Ruehl, I.
    Bauerfeind, I
    Untch, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S174 - S174
  • [40] Comparison of fluorescence in situ hybridization and immunohistochemical analysis for HER-2/neu detection in breast carcinoma.
    Li, Y
    Battaglia, T
    Davis, M
    Hankins, L
    Hagemeister, S
    Arthur, T
    Tawfik, O
    Persons, D
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 641 - 642
12345